Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-derived cardiomyocytes
Gene therapy is a promising option for severe forms of genetic diseases. We previously provided evidence for the feasibility of trans-splicing, exon skipping, and gene replacement in a mouse model of hypertrophic cardiomyopathy (HCM) carrying a mutation in MYBPC3, encoding cardiac myosin-binding pro...
Main Authors: | Prondzynski, M, Krämer, E, Laufer, S, Shibamiya, A, Pless, O, Flenner, F, Müller, O, Münch, J, Redwood, C, Hansen, A, Patten, M, Eschenhagen, T, Mearini, G, Carrier, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2017
|
Similar Items
-
The utilisation of hydrogels for iPSC-cardiomyocyte research
by: Patel, L, et al.
Published: (2023) -
Activation of autophagy ameliorates cardiomyopathy in Mybpc3-targeted knockin mice
by: Singh, SR, et al.
Published: (2017) -
Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model
by: Cumberland, MJ, et al.
Published: (2023) -
Geometry-dependent functional changes in iPSC-derived cardiomyocytes probed by functional imaging and RNA sequencing
by: Gaublomme, Jellert, et al.
Published: (2017) -
Modeling MELAS-associated cardiac defects using patient-specific iPSC-derived cardiomyocytes and cardiac organoids
by: Phua, Qian Hua
Published: (2018)